Koninklijke Philips NV

Koninklijke Philips NV (PHG) Stock Analysis

$25.740

+0.252 (+0.98%)At close

Loading chart…
High
26.045
Open
25.830
VWAP
25.83
Volume
1.34M
Mkt Cap
24.07B
Low
25.720
Amount
34.58M
EV/EBITDA, TTM
7.95

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others.

AI analysis of Koninklijke Philips NV (PHG)

Buy

Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.

Analyst Ratings (1)

Buy
1 Buy
0 Hold
0 Sell
Current: 25.74
Low
—
Average
—
High
—

Morgan Stanley

2026-09-11

Price Target

—

Equal Weight

UBS

2026-08-03

Price Target

—

Neutral

Deutsche Bank

2026-07-30

Price Target

—

Hold

JPMorgan

2026-07-29

Price Target

—

Neutral

Citi

2026-07-01

Price Target

—

Neutral

Valuation Metrics

The current forward P/E ratio for Koninklijke Philips NV (PHG) is 12.72, compared to its 5-year average forward P/E of 15.46.

Forward P/E

Fair
5Y Average P/E
15.46
Current P/E
12.72
Overvalued
21.26
Undervalued
9.66

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
9.42
Current EV/EBITDA
7.95
Overvalued
11.43
Undervalued
7.40

Forward P/S

Fair
5Y Average P/S
1.15
Current P/S
1.33
Overvalued
1.43
Undervalued
0.87

Alphio AI Price Scenarios for PHG

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%PHG

$30.22

Scenario price

B

Base

Base · 50%PHG

$25.07

Scenario price

B

Bear

Bear · 25%PHG

$24.03

Scenario price

Whales holding PHG

L

Lingotto Investment Management LLP

+ HoldingPHG

+24.44%

3M Return

W

W1M Asset Management Limited

+ HoldingPHG

+5.30%

3M Return

B

Becker Capital Management Inc

+ HoldingPHG

+4.53%

3M Return

M

Mondrian Investment Partners Limited

+ HoldingPHG

+2.68%

3M Return

B

Bestinver Gestión, S.A. SGIIC

+ HoldingPHG

+1.76%

3M Return

Events Timeline

2026-10-08 (ET)

09:30:00

Royal Philips Forms Global Clinical Advisory Board

2026-10-05 (ET)

09:30:00

Royal Philips Launches Sonicare 9900 Toothbrush at $379.99

2026-09-17 (ET)

09:30:00

Philips Installs First Rembra CT System in the U.S.

2026-08-11 (ET)

06:00:00

Philips and Exor Update Long-Term Relationship Agreement

News

PHG FAQ — answered by Alphio AI

Koninklijke Philips NV is a Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care businesses and Other. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease as well as oral healthcare and mother and child care support. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The Other segment comprises such items, as innovation, emerging businesses, royalties, among others. It operates in the Healthcare sector.

Philips NV (PHG) appears to be a good buy right now due to its strong financial indicators and positive market sentiment. The stock has shown a 5-day change of +6.19%, and its gross margin has improved to 49.31% in Q2 2026, indicating efficient cost management and profitability. However, a key risk is the significant selling pressure from hedge funds, which has increased by 30126.47% over the last quarter, suggesting potential volatility ahead.

1 analysts cover PHG: 1 rate it Buy, 0 Hold and 0 Sell.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading